Skip to main content
. 2010 Dec 1;3(6):373–379. doi: 10.1593/tlo.10196

Figure 1.

Figure 1

Erlotinib Cmax (ng/ml) (A) and AUC (B) after a single dose of erlotinib and capecitabine (closed symbols) compared with erlotinib alone (open symbols). Data for erlotinib alone were obtained from single-agent clinical trials at our institution.